Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David E. Einstein
Observed names:
David E Einstein,
David Einstein
Institution:
University of California, Irvine
Observed institutions:
Beth Israel Deaconess Medical Center,
Harvard University,
University of California, Irvine,
Long Beach Medical Center,
Tibor Rubin VA Medical Center,
VA Long Beach Healthcare System
show all 6
ORCID:
0000-0003-1584-4049
Observed ORCID:
0000-0003-1584-4049
OpenAlex ID:
A5060382432
An inducible Cre mouse for studying roles of the RPE in retinal physiology and disease
2021
·
Elliot H. Choi
, Susie Suh
, et al.
·
JCI Insight
·
34
PDF
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models
2024
·
Henri Leinonen
, Jianye Zhang
, et al.
·
Nature Communications
·
27
PDF
Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy
2021
·
Eliav Blum
, Jianye Zhang
, et al.
·
Journal of Medicinal Chemistry
·
21
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer
2025
·
Kei Mizuno
, Sheng-Yu Ku
, et al.
·
Nature Communications
·
20
PDF
Dominant role for pigment epithelial CRALBP in supplying visual chromophore to photoreceptors
2024
·
Marco Bassetto
, Alexander V. Kolesnikov
, et al.
·
Cell Reports
·
17
Jasmonate signaling and prey nutrient availability trigger distinct biochemical responses in the Drosera capensis feeding cycle
2026
·
Zane G Long
, Gemma R Takahashi
, et al.
·
PLANT PHYSIOLOGY
·
2
A disease-modifying therapy for retinal degenerations by drug repurposing
2021
·
Henri Leinonen
, Jianye Zhang
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
Show more works
View as search
Works count:
7
Citation count:
122
H-index:
5
I10-index:
5
Year
Topic
Type